Home/Vivace Therapeutics/Tracy Tang, Ph.D.
TT

Tracy Tang, Ph.D.

VP of Biology / Head of Biology

Vivace Therapeutics

Therapeutic Areas

Vivace Therapeutics Pipeline

DrugIndicationPhase
VT3989Refractory pleural and non-pleural mesothelioma; Advanced solid tumors with NF2 mutationsPhase 1/2